Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Microbot Medical Inc. (MBOT : NSDQ)

• Company Description    Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA. Number of Employees: 21

• Price / Volume Information    Yesterday's Closing Price: $4.05 Daily Weekly Monthly 20 Day Moving Average: 6,213,127 shares Shares Outstanding: 45.55 (millions) Market Capitalization: $184.46 (millions) Beta: 1.22 52 Week High: $4.67 52 Week Low: $0.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 29.39% 27.12% 12 Week 63.97% 48.94% Year To Date 261.61% 210.11%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 175 DERBY ST. BLD. 27 - HINGHAM,MA 02043 USA ph: 781-875-3605 fax: 781-556-5347 ir@microbotmedical.com http://www.microbotmedical.com

• General Corporate Information    Officers Harel Gadot - Chief Executive Officer; Chairman and President Rachel Vaknin - Chief Financial Officer Scott Burell - Director Martin Madden - Director Prattipati Laxminarain - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 59503A204 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/12/25 Share - Related Items Shares Outstanding: 45.55 Most Recent Split Date: 9.00 (0.07:1) Beta: 1.22 Market Capitalization: $184.46 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.07 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.34 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.85 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 41.18% vs. Previous Quarter: -25.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - -76.27 03/31/25 - -110.27 12/31/24 - -234.01 ROA 06/30/25 - -67.54 03/31/25 - -94.20 12/31/24 - -175.78 Current Ratio 06/30/25 - 12.06 03/31/25 - 16.19 12/31/24 - 2.37 Quick Ratio 06/30/25 - 12.06 03/31/25 - 16.19 12/31/24 - 2.37 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - 0.83 03/31/25 - 0.83 12/31/24 - 0.17 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©